切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2023, Vol. 17 ›› Issue (03) : 267 -271. doi: 10.3877/cma.j.issn.1674-3946.2023.03.010

论著

血清外泌体circ PVT1与circ 0014606在三阴性乳腺癌中的表达及临床意义
纪文鑫1, 王茂1, 邱春丽2, 李尚鹏3, 代引海1,()   
  1. 1. 712000 陕西咸阳,陕西中医药大学第二附属医院肿瘤乳腺外科
    2. 712000 陕西咸阳,咸阳市中心医院肿瘤介入科
    3. 712000 陕西咸阳,陕西省中医药大学研究生学院
  • 收稿日期:2022-09-21 出版日期:2023-06-26
  • 通信作者: 代引海

Expression and clinical significance of serum exosomes circ pvt1 and circ 0014606 in triple negative breast cancer

Wenxin Ji1, Mao Wang1, Chunli Qiu2, Shangpeng Li3, Yinhai Dai1,()   

  1. 1. The Second Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine Tumor breast surgery,Xianyang Shaanxi Province 712000,China
    2. Xianyang City Central Hospital Tumor Interventional Department,Xianyang Shaanxi Province 712000,China
    3. Graduate School of Shaanxi University of Traditional Chinese Medicine,Xianyang Shaanxi Province 712000,China
  • Received:2022-09-21 Published:2023-06-26
  • Corresponding author: Yinhai Dai
  • Supported by:
    Shaanxi Province 2022 Science and Technology Plan Project(2022SF-563); Discipline Innovation Team Project of Shaanxi University of Traditional Chinese Medicine(2019-YS03); Special Scientific Research Program of Education Department of Shaanxi Province(17JK0209)
引用本文:

纪文鑫, 王茂, 邱春丽, 李尚鹏, 代引海. 血清外泌体circ PVT1与circ 0014606在三阴性乳腺癌中的表达及临床意义[J/OL]. 中华普外科手术学杂志(电子版), 2023, 17(03): 267-271.

Wenxin Ji, Mao Wang, Chunli Qiu, Shangpeng Li, Yinhai Dai. Expression and clinical significance of serum exosomes circ pvt1 and circ 0014606 in triple negative breast cancer[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(03): 267-271.

目的

检测乳腺癌患者血清外泌体circ PVT1与circ 0014606的表达水平,分析两者表达水平与三阴性乳腺癌(TNBC)患者临床病理及预后的关系。

方法

回顾性分析2018年1月至2018年12月行手术治疗的84例乳腺癌患者资料,其中TNBC 46例,非三阴性乳腺癌(NTNBC)38例。另选同时期于我院进行健康体检的80例健康人群作为对照组。提取所有患者的血清外泌体,采用透射电镜和免疫印迹实验(Western blot)进行鉴定;采用qRT-PCR法分别检测TNBC、NTNBC及对照组患者外泌体中circ PVT1和circ 0014606表达水平。应用SPSS22.0分析数据,circ PVT1和circ 0014606表达水平与TNBC患者临床病理参数的关系,采用χ2Fisher精确检验;绘制Kaplan-Meier生存曲线分析circ PVT1和circ 0014606表达与患者预后的关系。以P<0.05为差异有统计学意义。

结果

透射电镜观察到,血清外泌体呈椭圆形双层膜囊泡结构;Western blot结果显示,外泌体特征蛋白CD9,CD63和CD81蛋白在外泌体中表达较上清液中明显升高。qRT-PCR结果显示,与对照组相比,TNBC组和NTNBC组患者血清外泌体circ PVT1和circ 0014606表达均显著上升,且TNBC患者的表达更为显著(P<0.05)。circ PVT1表达水平与TNBC患者肿瘤大小、组织学分级、TNM分期、病理类型及淋巴结转移有关(P<0.05);circ 0014606表达水平与TNBC患者组织学分级、TNM分期、病理类型及淋巴结转移有关(P<0.05Kaplan-Meier分析显示,circ PVT1高表达TNBC患者3年无病生存率为46.3%,显著低于circ PVT1低表达组的71.2%(P<0.05);circ 0014606高表达组TNBC患者3年无病生存率为40.8%,显著低于circ 0014606低表达组的68.0%(P<0.05)。

结论

血清外泌体circ PVT1与circ 0014606在乳腺癌中高表达,TNBC中表达更为显著,且与TNBC患者临床病理及预后关系密切,有望成为判断TNBC恶性程度及预后不良的特异性指标。

Objective

Expression and clinical significance of serum exosome circ PVT1 and circ 0014606 in triple negative breast cancer

Methods

Data of 84 patients with breast cancer who underwent surgical treatment from January 2018 to December 2018 were retrospectively analyzed,including 46 patients with TNBC and 38 patients with non-triple-negative breast cancer(NTNBC). Another 80 healthy people who underwent physical examination in our hospital during the same period were selected as the control group. The serum exosomes of all patients were extracted and identified by transmission electron microscopy and Western blot. The expression levels of circ PVT1 and circ 0014606 in exosomes of TNBC,NTNBC and control patients were detected by qRT-PCR. SPSS22.0 was used to analyze the data,and the relationship between the expression level of circ PVT1 and circ 0014606 and clinicpathological parameters of TNBC patients was analyzed by χ2 or Fisher exact test. Kaplan-Meier survival curves were drawn to analyze the relationship between circ PVT1 and circ 0014606 expression and prognosis. P<0.05 was considered to be statistically significant.

Results

Transmission electron microscopy(TEM)showed that the serum exosomes presented an elliptical bilayer vesicle structure. Western blot results showed that the expressions of exosome characteristic proteins CD9,CD63 and CD81 were significantly higher in exosome than in supernatant. qRT-PCR results showed that compared with the control group,The expression of circ PVT1 and circ 0014606 in serum exosomes in TNBC and NTNBC groups was significantly increased,and the expression was more significant in TNBC patients(P<0.05). The expression level of circ PVT1 was correlated with tumor size,histological grade,TNM stage,pathological type and lymph node metastasis in TNBC patients(P<0.05). The expression level of circ 0014606 was correlated with histological grade,TNM stage,pathological type and lymph node metastasis of TNBC patients(P<0.05). Kaplan-Meier analysis showed that the 3-year disease-free survival rate of TNBC patients with high circ PVT1 expression was 46.3%,which was significantly lower than 71.2% in the group with low circ PVT1 expression(P<0.05). The 3-year disease-free survival rate of TNBC patients in the circ 0014606 high expression group was 40.8%,significantly lower than 68.0% in the circ 0014606 low expression group(P<0.05).

Conclusion

Serum exosome circ PVT1 and circ 0014606 are highly expressed in breast cancer,and are more significantly expressed in TNBC. They are closely related to the clinicopathology and prognosis of TNBC patients,and are expected to be a specific indicator for judging the malignancy of TNBC and poor prognosis.

表1 qRT-PCR检测circ PVT1和circ 0014606表达所需引物序列
图1 血清外泌体结构鉴定及特征蛋白表达检测注:A=透射电镜鉴定外泌体结构(红色箭头标记);B=Western blot检测血清外泌体特征蛋白表达。
图2 三组患者血清外泌体circ PVT1和circ 0014606表达水平比较注:与对照组比较,aP<0.05;与NTNBC组比较,bP<0.05。
表2 46例行乳腺癌改良根治术TNBC患者血清外泌体circ PVT1、circ 0014606表达与临床病理参数的关系
图3 circ PVT1、circ 0014606表达对TNBC患者无病生存的影响
[1]
Cao WChen HDYu YW,et al. Changing profiles of cancer burden worldwide and in China:a secondary analysis of the global cancer statistics 2020[J]. Chin Med J(Engli)2021134(7):783-791.
[2]
孙晓萌,高社干. 三阴性乳腺癌的临床治疗现状及新进展[J]. 实用癌症杂志202035(06):1037-1039.
[3]
陈艺昀,江明杰,陈志龙,等. 外泌体介导肿瘤发生发展进程的研究进展[J]. 生命科学201931(06):558-565.
[4]
汪洁,苏丽清,黄淑铃,等. 外泌体中环状RNA在癌症早期诊断中的研究进展[J]. 医学综述202228(12):2373-2378.
[5]
Li CXu X. Biological functions and clinical applications of exosomal non-coding RNAs inhepatocellular carcinoma[J]. Cell MolLife Sci201976(21):4203-4219.
[6]
徐玉彬,崔恒宓,薛峰,等. 外泌体源性miRNA与结直肠癌诊断的研究进展[J/CD]. 中华普外科手术学杂志(电子版),201610(06):535-537.
[7]
张雯琼,金春明,尹贵彬. circPVT1与lncGAS5在乳腺癌中的表达[J]. 牡丹江医学院学报201940(06):29-33.
[8]
Huang MLi TWang Q,et al. Silencing circPVT1 enhances radiosensitivity in non-small cell lung cancer by sponging microRNA-1208[J]. Cancer biomark202131(3):263-279.
[9]
Rao MZhu YQi L,et al. Circular RNA profiling in plasma exosomes from patients with gastric cancer[J]. Oncol Lett202020(3):2199-2208.
[10]
Moore-Smith LForero-Torres AStringer-Reasor E. Future Developments in Neoadjuvant Therapy for Triple-Negative Breast Cancer[J]. Surg Clin North Am201898(4):773-785.
[11]
Kalluri RLebleu VS. The biology,function,and biomedical applications of exosomes[J]. Science2020367(6478):eaau6977.
[12]
李平,吴涛,贺强. miR-126在肝癌中表达及其与临床病理特征、预后的关系[J/CD]. 中华普外科手术学杂志(电子版),201913(01):37-40.
[13]
Li JSun DPu W,et al. Circular RNAs in cancer:biogenesis,function,and clinical significance[J]. Trends Cancer20206(4):319-336.
[14]
Sui HZhu CLi Z,et al. Propofol suppresses gastric cancertumorigenesis by modulating the circular RNA-PVT1/miR-195-5p/E26oncogene homolog 1 axis[J]. Oncol Rep202044(4):1736-1746.
[15]
Chen JLi YZheng Q,et al. Circular RNA profile identifies circPVT1 as a proliferative factor and prognostic marker in gastric cancer[J]. Cancer Lett2017388(3):208-219.
[16]
Yao WGuo PMu Q,et al. Exosome-Derived Circ-PVT1 Contributes to Cisplatin Resistance by Regulating Autophagy,Invasion,and Apoptosis Via miR-30a-5p/YAP1 Axis in Gastric Cancer Cells[J]. Cancer Biother Radiopharm202136(4):347-359.
[17]
Mai SZhang ZMi W. Upregulation of circ_PVT1 and circ_001569 Indicate Unfavorable Prognosis in Colorectal Cancer[J]. Ann Clin Lab Sci202151(1):55-60.
[18]
Cao LZhou XDing X,et al. Knockdown of circ-PVT1 inhibits the progression of lung adenocarcinoma and enhances the sensitivity to cisplatin via the miR-429/FOXK1 signaling axis[J]. Mol Med Rep202124(4):684.
[19]
杜倩,朱郭增,邵银灿,等. Circ PVT1通过靶向miR-605-3p介导的Wnt/β-catenin信号通路对乳腺癌细胞增殖迁移及侵袭的影响[J]. 中国妇幼保健202136(22):5294-5299.
[1] 李洋, 蔡金玉, 党晓智, 常婉英, 巨艳, 高毅, 宋宏萍. 基于深度学习的乳腺超声应变弹性图像生成模型的应用研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(06): 563-570.
[2] 周荷妹, 金杰, 叶建东, 夏之一, 王进进, 丁宁. 罕见成人肋骨郎格汉斯细胞组织细胞增生症被误诊为乳腺癌术后骨转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 380-383.
[3] 河北省抗癌协会乳腺癌专业委员会护理协作组. 乳腺癌中心静脉通路护理管理专家共识[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 321-329.
[4] 刘晨鹭, 刘洁, 张帆, 严彩英, 陈倩, 陈双庆. 增强MRI 影像组学特征生境分析在预测乳腺癌HER-2 表达状态中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 339-345.
[5] 张晓宇, 殷雨来, 张银旭. 阿帕替尼联合新辅助化疗对三阴性乳腺癌的疗效及预后分析[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 346-352.
[6] 邱琳, 刘锦辉, 组木热提·吐尔洪, 马悦心, 冷晓玲. 超声影像组学对致密型乳腺背景中非肿块型乳腺癌的诊断价值[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 353-360.
[7] 程燕妮, 樊菁, 肖瑶, 舒瑞, 明昊, 党晓智, 宋宏萍. 乳腺组织定位标记夹的应用与进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 361-365.
[8] 涂盛楠, 胡芬, 张娟, 蔡海峰, 杨俊泉. 天然植物提取物在乳腺癌治疗中的应用[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(06): 366-370.
[9] 韩萌萌, 冯雪园, 马宁. 乳腺癌改良根治术后桡神经损伤1例[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 117-118.
[10] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[11] 张志兆, 王睿, 郜苹苹, 王成方, 王成, 齐晓伟. DNMT3B与乳腺癌预后的关系及其生物学机制[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 624-629.
[12] 王玲艳, 高春晖, 冯雪园, 崔鑫淼, 刘欢, 赵文明, 张金库. 循环肿瘤细胞在乳腺癌新辅助及术后辅助治疗中的应用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 630-633.
[13] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
[14] 袁雨涵, 杨盛力. 体液和组织蛋白质组学分析在肝癌早期分子诊断中的研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 883-888.
[15] 董晓斌, 张静, 苏莎莎, 莎比亚·沙吾提, 盛好. 溃疡性结肠炎患者相关环状RNA 差异表达谱分析及功能研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 499-509.
阅读次数
全文


摘要